Form 4 for CL Colgate-Palmolive
Accepted 2022-02-04 00:00:00 ET · period of report 2022-02-02 · accession 0001225208-22-001507 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-04 | 2022-02-02 | CL | NORRINGTON LORRIE M | Dir | S - Sale+OE | $82.75 | -5,389 | 23.5K | -19% | -$445.9K |
| D | 2022-02-04 | 2022-02-02 | CL | NORRINGTON LORRIE M | Dir | M - OptEx | $71.76 | +5,389 | 28.9K | +23% | +$386.7K |
| D | 2022-02-04 | 2022-02-02 | CL | NORRINGTON LORRIE M | Dir | M - OptEx | $0.00 | -5,389 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-02 | S | D | 5,389 | $82.75 | 23,494 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-02 | M | A | 5,389 | $71.76 | 28,883 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-02-02 | M | D | 5,389 | $0.00 | 0 | D | $71.76 · — to 2022-05-09 | 5,389 Common Stock | (F3) Option became exercisable in one-third increments beginning on the first anniversary of the May 9, 2016 grant date. |